Updated Jul 16, 2026
Balthaser Kevin is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Kevin Balthaser is associated with Aclaris Therapeutics, Inc., a biotechnology company focused on developing and commercializing innovative therapeutics for dermatological and other conditions. Specific details about his role and contributions to the company are not widely documented.
| Role | Insider |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-03 | ACRS | Aclaris Therapeutics, Inc. | F — Tax withholding / forfeiture | 677 | $2.87 | $2K |
| 2026-03-03 | ACRS | Aclaris Therapeutics, Inc. | M — Option exercise | 2.4K | — | |
| 2026-02-05 | ACRS | Aclaris Therapeutics, Inc. | F — Tax withholding / forfeiture | 6.4K | $3.47 | $22K |
| 2026-02-05 | ACRS | Aclaris Therapeutics, Inc. | M — Option exercise | 22.0K | — | |
| 2026-02-03 | ACRS | Aclaris Therapeutics, Inc. | F — Tax withholding / forfeiture | 5.0K | $3.51 | $17K |
| 2026-02-03 | ACRS | Aclaris Therapeutics, Inc. | M — Option exercise | 14.8K | — |
Kevin Balthaser is associated with Aclaris Therapeutics, Inc., a biotechnology company focused on developing and commercializing innovative therapeutics for dermatological and other conditions. Specific details about his role and contributions to the company are not widely documented.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Balthaser Kevin profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.